Individuals with germline mutations in PTCH1 (Gorlin syndrome) are susceptible to multiple malignancies such as basal cell carcinoma (BCC), medulloblastoma, and to a lesser extent RMS [66]. The gene discussed is PTCH1; the disease is skin basal cell carcinoma.